Viral Hepatitis Among African Immigrants with Hepatocellular Carcinoma in Minnesota: High Prevalence Yet Low Awareness.
Prowpanga UdompapCarlos G MoscosoChimaobi AnugwomMandip KcNicholas LimJohn LakeMohamed HassanPublished in: Journal of immigrant and minority health (2022)
We aimed to study the virologic profile of immigrants from Africa with viral hepatitis-related hepatocellular carcinoma (HCC) who received care at our institution. We conducted a descriptive study among African-born patients with HCC who received care at University of Minnesota Medical Center from 2011 to 2018. We analyzed the prevalence, virologic profiles and treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections prior to HCC diagnosis. 74 African-born patients with HCC were eligible for analysis. 54 had HCV and 20 had HBV infection. 80% of HBV patients were treated but remained with inadequate viral suppression at the time of HCC diagnosis while only 39% of HCV patients were treated prior to HCC diagnosis. Lost to follow up was common in both groups. Our findings suggest that there is a significant gap in appropriate viral hepatitis care in an African immigrant population in Minnesota. Culturally-appropriate strategies are needed to bridge this gap.
Keyphrases
- hepatitis b virus
- hepatitis c virus
- newly diagnosed
- end stage renal disease
- healthcare
- sars cov
- ejection fraction
- palliative care
- liver failure
- human immunodeficiency virus
- risk factors
- prognostic factors
- quality improvement
- peritoneal dialysis
- pain management
- patient reported outcomes
- preterm infants
- affordable care act
- low birth weight
- patient reported
- preterm birth